Patent Assignment
Reel/Frame 069774/0141
Assignment of Assignor's Interest
Recorded: 2025-01-07
Pages: 4
Assignor
EVOTEC INTERNATIONAL GMBH
Executed: 2024-12-05
Assignee
BREAKPOINT THERAPEUTICS GMBH
ESSENER BOGEN 7, HAMBURG, 22419, GERMANY
Covered Properties
(2)
Novel Compounds, Compositions, and Therapeutic Uses Thereof
Dna Polymerase Theta Inhibitor for Treatment of Cancer
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 9, 2024
From: HOLLICK, JONATHAN
To: BREAKPOINT THERAPEUTICS GMBH
Reel/Frame 068524/0523 →
Assignment of Assignor's Interest
Sep 9, 2024
From: HOLLICK, JONATHAN
To: BREAKPOINT THERAPEUTICS GMBH
Reel/Frame 068525/0337 →
Assignment of Assignor's Interest
Jan 7, 2025
From: MALASSIS, JULIEN GILBERT JACQUES
To: EVOTEC (FRANCE) SAS
Reel/Frame 069774/0056 →
Assignment of Assignor's Interest
Jan 7, 2025
From: CORELLA, ANDREA GUERRERO; FLANAGAN, STUART ROBERT; SMITH, MATTHEW RAYMOND; YULE, IAN ANDREW
To: EVOTEC (UK) LIMITED
Reel/Frame 069774/0063 →
Assignment of Assignor's Interest
Jan 7, 2025
From: EVOTEC (FRANCE) SAS
To: EVOTEC INTERNATIONAL GMBH
Reel/Frame 069774/0091 →
Assignment of Assignor's Interest
Jan 7, 2025
From: EVOTEC (UK) LIMITED
To: EVOTEC INTERNATIONAL GMBH
Reel/Frame 069774/0137 →